Stomach 'EKG' could spot hidden gut problems
NCT ID NCT05812339
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new device called Gastric Alimetry that records the stomach's electrical activity through electrodes placed on the belly. Researchers want to see if it can reliably detect abnormal stomach rhythms in people with conditions like gastroparesis and functional dyspepsia. 200 adults (both healthy and with stomach symptoms) will wear the device for 4 hours after a meal. The goal is to validate the device as a diagnostic tool, not to treat any condition.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Gastric Alimetry System (a device with electrodes placed on the abdomen to record stomach electrical activity)
- What this could lead to
- If successful, this device could become a new, non-invasive tool to help doctors diagnose stomach motility problems more accurately.
- What could go wrong
- This is an early observational study to validate the device, not a treatment trial. It may not lead to a widely available diagnostic test, and skin irritation from the electrodes is possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2022
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adults living in the Calgary Alberta region.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Healthy Population: * Adults aged 18 years and over * Able to understand the risks/benefits of the study * Able to give written informed consent * No active gastrointestinal symptoms or pathology * Resides in the Calgary, Alberta area Patient Population: * Adults aged 18 years and over * BMI \> 35 * Able to understand the risks/benefits of the study * Able to give written informed consent * Patients meeting Rome IV Criteria for functional dyspepsia, or a nausea and vomiting disorder * Patients with gastroparesis defined on a standardized gastric scintigraphy study * Resides in the Calgary, Alberta area Exclusion Criteria: Healthy Population: * Under 18 years of age * BMI \> 35 * Taking medications known to affect GI motility or the mid-gut axis (eg antidepressants, anti-anxiety medication, prokinetics, opiates) * Metabolic, neurogenic, or endocrine disorders known to cause gastrointestinal dysmotility (eg. Multiple Sclerosis, Parkinson's disease, hypothyroidism) * Known current GI infection (includes H. pylori when being actively treated) * Known current inflammatory bowel disease * Known current GI malignancy * Known GI functional or motility disorders * Previous gastroduodenal surgery * GI functional or motility disorders * Pregnant women * Open abdominal wounds or abdominal skin not intact (eg rash, abrasions, weeping tissue) * Fragile skin evidence by high susceptibility to skin tears or skin that bruises and breaks easily * Allergy to adhesives * History of allergy or intolerance to ingredients in the meal (nutrient drink, Ensure or similar and Clif bar or similar) * No vulnerable groups such as; prisoners, individuals with known cognitive impairment, or institutionalised individuals be involved * Regular cannabis use * Diagnosed with, or suspected to have life-threatening conditions that could result in immediate danger Patient Population: * Under 18 years of age * BMI \> 35 * Metabolic, neurogenic, or endocrine disorders known to cause gastrointestinal dysmotility (eg. Multiple Sclerosis, Parkinson's disease, hypothyroidism) * Known current GI infection (includes H. pylori when being actively treated) * Known current inflammatory bowel disease * Known current GI malignancy * Previous gastroduodenal surgery * Open abdominal wounds or abdominal skin not intact (eg rash, abrasions, weeping tissue) * Fragile skin evidence by high susceptibility to skin tears or skin that bruises and breaks easily * Allergy to adhesives * Pregnant women * History of allergy or intolerance to ingredients in the meal (nutrient drink, Ensure or similar and Clif bar or similar) * No vulnerable groups such as; prisoners, individuals with known cognitive impairment, or institutionalised individuals be involved * Regular cannabis use except in the case of CHS * Diagnosed with, or suspected to have life-threatening conditions that could result in immediate danger * Inability to remain in a relaxed reclined position for the test duration
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cannabinoid hyperemesis syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Calgary
Calgary, Alberta, T2N 4Z6, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ultrasound could reveal when ICU tube feeding fails
- Could a nickel allergy explain your Child's stomach pain?
- Stomach sensor may unmask hidden effects of weight-loss drugs
- A sticker-based stomach scan may replace radioactive tests for a chronic digestive disorder
- Can a stomach muscle cut tame diabetes blood sugar?
- Can a pudding snack reveal how the brain misreads the stomach?